Skip to content

Finnish Tennis Elbow Trial Pilot Study

Finnish Tennis Elbow Trial Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02425982
Acronym
FINITE
Enrollment
99
Registered
2015-04-24
Start date
2015-08-31
Completion date
2018-03-15
Last updated
2025-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tennis Elbow

Keywords

Tennis Elbow, Lateral elbow pain, Latera epicondylitis

Brief summary

The study aims to investigate the natural course and the results of operative treatment of chronic tennis elbow (TE). Chronic is defined as symptoms having lasted for more than a year. The investigators will also study the effect of pain catastrophising on the subjective outcome, the patient acceptable symptomatic state and the response shift phenomenon in TE. The study will also ascertain the feasibility of a multi-center randomised, controlled trial (RCT), and test and refine the co-operation and interaction of the planned RCT centers.

Detailed description

Objectives: 1. To study the natural course of tennis elbow/spontaneous recovery of chronic (lasting for over 12 months) tennis elbow and the results of surgery in a pragmatic setting. 2. To investigate the patients' expectations of the treatment, and define the patient acceptable symptomatic state, or PASS, in tennis elbow. 3. To investigate the effect of pain behaviour on treatment results and PASS. 4. To delineate the existence of a potential response shift -phenomenon in patients with a tennis elbow. 5. To determine the feasibility of a prospective, placebo-controlled, randomised trial by finding out the actual number of patients in each center and those that may be suitable for the FINITE-RCT. The investigators will also test the functioning and response of the planned outcome measures in this environment and for this purpose. Study setting The study is carried out as a prospective open-label multi-center cohort study. The study was originally planned with a follow-up up to 10 years, but the cost-benefit of the long term follow-up was evaluated after the completion of one year data collection, and the decision was made to shorten the follow-up to include two year data, but no further follow-ups.

Interventions

The exact treatment depends on the surgeon, but the majority are anticipated to be elbow arthroscopy followed by either arthroscopic or open extensor carpi radialis brevis release.

PROCEDUREConservative treatment

The treatment consists of physiotherapy, activity modification, pain medication and watchful waiting. Injection therapies will be avoided.

Sponsors

University of Helsinki
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
35 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Clinically diagnosed tennis elbow defined as: Pain on the lateral side of the elbow, made worse by pressure applied on the lateral epicondyle of the humerus and during resisted extension of the wrist or when making a fist with the elbow joint straight. 2. Duration of symptoms over 10 months 3. Age between 35 and 60 years 4. Ability to fill in Finnish questionnaires 5. Written informed consent

Exclusion criteria

1. Earlier fracture or dislocation in the elbow joint area 2. Earlier surgical treatment of the same elbow joint 3. Congenital deformity in the elbow 4. Systemic muscle, tendon, nerve or joint disease 5. Other problems causing pain the elbow joint: 1. Pain in the medial epicondyle of the elbow 2. Pain in the biceps muscle tendon 3. Painful snapping or crepitus of elbow joint 4. Instability of elbow joint (table top, posterolateral drawer test) 6. A passive movement limitation of more than 10 degrees in the elbow joint 7. Abnormal finding in an elbow joint X-ray. An elbow joint X-ray is a routine examination of elbow symptoms.

Design outcomes

Primary

MeasureTime frameDescription
Global improvement6 monthsA six-point Likert scale (much worse - worse - no change - better - much better - complete recovery) will be used and the patient is asked how the elbow symptoms are compared to the situation at the time of the initial visit and inclusion to the study.
Oxford Elbow Score6 monthsOxford Elbow Score (OES) is a three-dimensional questionnaire consisting of 12 multiple-choice questions answered by the patient. OES has been validated for patients with surgically treated elbow problems. OES is the most robust elbow-specific PROM available currently.

Secondary

MeasureTime frameDescription
Success rateup to 2 yearsSuccess is defined at any follow-up time point as patients who report much better or complete recovery in the second primary outcome question.
Relapsesup to 2 yearsRelapses are calculated from the Likert answers so that if the patient reports much better or completely healed at time point X and the answer is better or any of the poorer alternatives on follow-up point X+1, this is interpreted as a relapse for X+1 point in time. Relapses are calculated for each follow-up point in time and the patients are considered to remain in relapse until they report much better or completely healed.
Satisfaction with the treatment processup to 2 yearsthis is evaluated with the question On a scale of 0 to 10, (with 10 on as 'very satisfied' and 0 as 'very dissatisfied'), how satisfied are you with the treatment you have received as a whole? The outcome measure will be assessed as a secondary outcome at 6, 12, 26 and 52 weeks and then at 2, 3, 4, 5 and 10 years
Time off workup to 2 yearsNumber of sick leave days due to elbow symptoms.
Global improvementup to 2 yearsA six-point Likert scale (much worse - worse - no change - better - much better - complete recovery) will be used and the patient is asked how the elbow symptoms are compared to the situation at the time of the initial visit and inclusion to the study. The outcome measure will be assessed at 6, 12, 26 and 52 weeks and then at 2, 3, 4, 5 and 10 years
Oxford Elbow Scoreup to 2 yearsOES will be assessed as a secondary outcome at 6, 12, 26 and 52 weeks and then at 2 years
Complications and adverse effectsup to 2 yearsComplications and adverse events related to treatment of the elbow. Predefined complications are: infection, iatrogenic injuries (especially nerve), crps, anaesthetic complications.
QuickDASHup to 2 yearsQuickDASH is a validated patient reported outcome measure of the function the upper extremities. It consists of 11 questions and 4 work-related questions. An approved Finnish translation has been made earlier. The outcome measure will be assessed as a secondary outcome at 6, 12, 26 and 52 weeks and then at 2, 3, 4, 5 and 10 years.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026